Opko Health, Inc.
OPK
$1.90
$0.010.53%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.76% | -4.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.76% | -4.70% | |||
| Cost of Revenue | -20.26% | 4.95% | |||
| Gross Profit | 377.45% | -58.80% | |||
| SG&A Expenses | -31.74% | 42.69% | |||
| Depreciation & Amortization | -0.44% | 0.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.83% | 15.19% | |||
| Operating Income | 69.11% | -73.95% | |||
| Income Before Tax | -27.77% | 557.41% | |||
| Income Tax Expenses | -10.97% | 8,502.50% | |||
| Earnings from Continuing Operations | -43.64% | 341.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.64% | 341.53% | |||
| EBIT | 69.11% | -73.95% | |||
| EBITDA | 89.05% | -121.54% | |||
| EPS Basic | -42.18% | 341.89% | |||
| Normalized Basic EPS | 224.37% | -1,390.36% | |||
| EPS Diluted | -44.65% | 314.86% | |||
| Normalized Diluted EPS | 227.11% | -997.59% | |||
| Average Basic Shares Outstanding | -2.57% | -0.37% | |||
| Average Diluted Shares Outstanding | -4.66% | 43.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
